Orphan Drug Market Shows Steady Growth


A recent report by Kalorama predicts major growth in the global Orphan Drugs market;

The world orphan drug market reached $ 61 billion in 2012, according to Kalorama Information. The healthcare market research publisher says the increasing incidence of diseases affecting the aged will drive the market to increase at a rate of 11.5% throughout the forecast period, reaching a value of $105.2 billion by 2017.


Download the press release here